Skip to main content
Premium Trial:

Request an Annual Quote

Olivier Elemento and Anshul Kundaje

Freenome has announced the formation of its scientific advisory board including inaugural members Olivier Elemento and Anshul Kundaje.

Elemento is director of the Englander Institute for Precision Medicine, head of the Cancer Systems Biology Laboratory, and associate professor of computational genomics in computational biomedicine at Weill Cornell Medical College. He also serves as co-assistant dean for scientific computing, associate director of the Institute for Computational Biomedicine, and co-chair of the Genetics, Epigenetics and Systems Biology Program at the Meyer Cancer Center. 

Kundaje is an assistant professor of genetics and computer science at Stanford University, focused on computational regulatory genomics. He previously led integrative analysis efforts for the ENCODE Project and the Roadmap Epigenomics Project. 

According to Freenome, the new SAB will work closely with the company's management team to advance the development of the firm's technology platform and commercial disease screening products.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.